
A new AI-powered, imaging-based technology that creates accurate three-dimensional models of tumors, veins and other soft tissue offers a promising new method to help surgeons operate on, and better treat, breast cancers.
The technology, from Illinois-based startup SimBioSys, converts routine black-and-white MRI images into spatially accurate, volumetric images of a patient's breasts. It then illuminates different parts of the breast with distinct colors - the vascular system, or veins, may be red; tumors are shown in blue; surrounding tissue is gray.
Surgeons can then easily manipulate the 3D visualization on a computer screen, gaining important insight to help guide surgeries and influence treatment plans. The technology, called TumorSight Viz, calculates key surgery-related measurements, including a tumor's volume and how far tumors are from the chest wall and nipple.
It also provides key data about a tumor's volume in relation to a breast's overall volume, which can help determine - before a procedure begins - whether surgeons should try to preserve a breast or choose a mastectomy, which often presents cosmetic and painful side effects. Last year, TumorSight received FDA clearance.
Across the world, nearly 2.3 million women are diagnosed with breast cancer each year, according to the World Health Organization. Every year, breast cancer is responsible for the deaths of more than 500,000 women. Around 100,000 women in the U.S. annually undergo some form of mastectomy, according to the Brigham and Women's Hospital.
According to Jyoti Palaniappan, chief commercial officer at SimBioSys, the company's visualization technology offers a step-change improvement over the kind of data surgeons typically see before they begin surgery.
Typically, surgeons will get a radiology report, which tells them, Here's the size and location of the tumor,' and they'll get one or two pictures of the patient's tumor, said Palaniappan. If the surgeon wants to get more information, they'll need to find the radiologist and have a conversation with them - which doesn't always happen - and go through the case with them.
Dr. Barry Rosen, the company's chief medical officer, said one of the technology's primary goals is to uplevel and standardize presurgical imaging, which he believes can have broad positive impacts on outcomes.
We're trying to move the surgical process from an art to a science by harnessing the power of AI to improve surgical planning, Dr. Rosen said.
SimBioSys uses NVIDIA A100 Tensor Core GPUs in the cloud for pretraining its models. It also uses NVIDIA MONAI for training and validation data, and NVIDIA CUDA-X libraries including cuBLAS and MONAI Deploy to run its imaging technology. SimBioSys is part of the NVIDIA Inception program for startups.
SimBioSys is already working on additional AI use cases it hopes can improve breast cancer survival rates.
It has developed a novel technique to reconcile MRI images of a patient's breasts, taken when the patient is lying face down, and converts those images into virtual, realistic 3D visualizations that show how the tumor and surrounding tissue will appear during surgery - when a patient is lying face up.
This 3D visualization is especially relevant for surgeons so they can visualize what a breast and any tumors will look like once surgery begins.
To create this imagery, the technology calculates gravity's impact on different kinds of breast tissue and accounts for how different kinds of skin elasticity impact a breast's shape when a patient is lying on the operating table.
The startup is also working on a new strategy that also relies on AI to quickly provide insights that can help determine the risk of recurrence to support providers in determining the best treatment to avoid cancer recurrence.
Currently, hospital labs run pathology tests on tumors that surgeons have removed. The biopsies are then sent to a different outside lab, which conducts a more comprehensive molecular analysis.
This process routinely takes up to six weeks. Without knowing how aggressive a cancer in the removed tumor is, or how that type of cancer might respond to different treatments, patients and doctors are unable to quickly chart out treatment plans to avoid recurrence.
SimBioSys's new technology uses an AI model to analyze the 3D volumetric features of the just-removed tumor, the hospital's initial tumor pathology report and a patient's demographic data. From that information, SimBioSys generates - in a matter of hours - a risk analysis for that patient's cancer, which can help doctors quickly determine the best treatment to avoid recurrence.
According to SimBioSys's Palaniappan, the startup's new method matches or exceeds the risk of recurrence scoring ability of more traditional methodologies, based upon its internal studies. It also takes a fraction of the time of these other methods while costing far less money.
North America Stories
23/12/2025
Share Share by:
Copy link
Facebook
X
Whatsapp
Pinterest
Flipboard...
23/12/2025
Share Share by:
Copy link
Facebook
X
Whatsapp
Pinterest
Flipboard...
23/12/2025
Share Share by:
Copy link
Facebook
X
Whatsapp
Pinterest
Flipboard...
23/12/2025
Share Share by:
Copy link
Facebook
X
Whatsapp
Pinterest
Flipboard...
23/12/2025
Share Share by:
Copy link
Facebook
X
Whatsapp
Pinterest
Flipboard...
23/12/2025
Taking the Stage at Carnegie Hall-On a Global Scale Boston Conservatory Orchestra students reflect on their epic concert marking the 80th session of the UN Gene...
22/12/2025
SVG New Sponsor Spotlight: Presidio's Neerav Shah on the Role of Its Captiva...
22/12/2025
Hitting the bullseye: Sky Sports readies itself for the biggest PDC World Darts ...
22/12/2025
Unique skillset: Bringing new directors to the world of darts at The Worlds with...
22/12/2025
Gravity Media prepares for a flight of fancy with the PDC World Darts Championsh...
22/12/2025
One hundred and eighty: Gravity Media on hitting the production bullseye at the ...
22/12/2025
The Famous Group's Jon Slusser on Fascinating Fans Through Immersive Content...
22/12/2025
ESPN's Meg Aronowitz on Continuing High-Quality Broadcasts of Collegiate Spo...
22/12/2025
ESPN Takes Data-Driven Storytelling to New Heights with MNF Playbook with Next ...
22/12/2025
Paramount Scores Largest Share Increase Among Distributors as Paramount and CBS...
22/12/2025
New multi-year deal integrates Roku's data to fuel Nielsen's measurement suite
Roku gains access to Nielsen's streaming ratings, showing The Roku C...
22/12/2025
Share Share by:
Copy link
Facebook
X
Whatsapp
Pinterest
Flipboard...
22/12/2025
Berklee Wrapped 2025: Our Top News and Stories A look back at a year highlighted by faculty milestones, major film and television projects, Bob Dylan's ho...
22/12/2025
The works of Plato state that when humans have an experience, some level of change occurs in their brain, which is powered by memory - specifically long-term me...
22/12/2025
Workflows allow you to create a sequence of planned events which may be added to your template(s) or inserted directly into your sequential or background playli...
22/12/2025
Back to All News
Global Anime Hits and New Releases Take Center Stage at Jump Festa 2026
Entertainment
22 December 2025
GlobalJapan
Link copied to clipboar...
21/12/2025
Back to All News
Legoshi and Haru's Story Reaches Its Finale: BEASTARS Fin...
20/12/2025
Atomos announced the immediate availability of a new firmware update for its Ninja TX GO and Ninja TX monitor-recorders, unlocking ProRes RAW recording from the...
20/12/2025
CJP Broadcast has completed the digitisation of the European Gymnastics tape archive, converting 328 tapes containing more than forty years of recorded material...
20/12/2025
Bitmovin, the leading provider of video streaming solutions, today announced the launch of the Stream Lab MCP Server, to give AI agents and large language model...
20/12/2025
Share Share by:
Copy link
Facebook
X
Whatsapp
Pinterest
Flipboard...
20/12/2025
Share Share by:
Copy link
Facebook
X
Whatsapp
Pinterest
Flipboard...
20/12/2025
Share Share by:
Copy link
Facebook
X
Whatsapp
Pinterest
Flipboard...
20/12/2025
Share Share by:
Copy link
Facebook
X
Whatsapp
Pinterest
Flipboard...
20/12/2025
Share Share by:
Copy link
Facebook
X
Whatsapp
Pinterest
Flipboard...
20/12/2025
Share Share by:
Copy link
Facebook
X
Whatsapp
Pinterest
Flipboard...
20/12/2025
Barack Obama Includes Laufey on His 2025 Favorite Music List The former presidents roundup of books, music, and movies includes a song from the Berklee alums ...
20/12/2025
Study reveals a key hormonal circuit in the kidneys Scripps Research scientists identify the protein that helps kidney cells regulate renin, providing foundatio...
19/12/2025
SVG Sit-Down: Diversified's Jared Timmins on AI for Broadcast Sports and Cre...
19/12/2025
2025 SVG Summit Audio Recap: Say What?The Audio Production and Distribution Workshop at the SVG Summit 20 took on issues including speech intelligibility, Next-...
19/12/2025
Gamified fun: Channel 5 on its NFL Big Game Night ambitions with Hungry Bear Med...
19/12/2025
College Football Playoff Preview: For ESPN, Round 1 is a Fantastic Yet Familia...
19/12/2025
AWS's Jason Dvorkin on Developing Partnerships With the NBA and PGA Tour, Em...
19/12/2025
Netflix Kicks Off Packed Sports Week with Paul-Joshua Fight Before Shifting to N...
19/12/2025
SVG New Sponsor Spotlight: Presidio's Nareev Shah on the Role of Its Captiva...
19/12/2025
Mounted to the pylon of an AH-1Z Viper helicopter, a Red Wolf vehicle successful...
19/12/2025
L3Harris technology for the SDA Tranche 3 Tracking Layer program will provide in...
19/12/2025
Partnership brings Nielsen ONE measurement activation directly into XR's adv...
19/12/2025
Share Share by:
Copy link
Facebook
X
Whatsapp
Pinterest
Flipboard...
19/12/2025
Share Share by:
Copy link
Facebook
X
Whatsapp
Pinterest
Flipboard...
19/12/2025
Berklee Announces Spring 2026 Signature Series This season's highlights include the Gospel Extravaganza, the 40th International Folk Festival, special gue...
19/12/2025
Performing arts centres across the globe have doubled down on live production infrastructure in recent years. For venues like the Queensland Performing Arts Cen...
19/12/2025
Share Share by:
Copy link
Facebook
X
Whatsapp
Pinterest
Flipboard...
19/12/2025
Share Share by:
Copy link
Facebook
X
Whatsapp
Pinterest
Flipboard...